510(k) Report

510(k) · Cleared

Cleared

MedtFine Blood Lancet

K221383510(k) TraditionalCleared Sep 21, 2022131-day reviewClass II21 CFR 878.4850

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Shanghai Carelife International Trading Co., Ltd. · QRK Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature

Cleared on Sep 21, 2022 as substantially equivalent to K192666 (Promisemed Hangzhou Meditech Co., Ltd., 2019) after a 131-day review. Its family tree reaches back 3 generations to 1982.

Decided
Sep 21, 2022
Review
131 days
Class
Class II
Product code
QRK
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K822209 (1982). 5 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 3 generations backK822209 AutolancetBd Becton Dickinson Vacutainer Systems Preanalytic · 1982
  2. 2 generations backK101145 Surgilance Safety Lancets, Models SLN100, SLN200, SLN240, SLN300…Medipurpose Pte., Ltd. · 2010
  3. 1 generation backK192666 Promisemed Blood Lancet, VeriFine Safety Lancet, VeriFine…Promisemed Hangzhou Meditech Co., Ltd. · 2019
  4. This deviceK221383 MedtFine Blood LancetShanghai Carelife International Trading Co., Ltd. · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K822209AutolancetBd Becton Dickinson Vacutainer Systems Preanalytic1982—
−2K101145Surgilance Safety Lancets, Models SLN100, SLN200, SLN240, SLN300, SLB200, SLB250Medipurpose Pte., Ltd.2010—
−1K192666Promisemed Blood Lancet, VeriFine Safety Lancet, VeriFine Mini-Safety LancetPromisemed Hangzhou Meditech Co., Ltd.2019—
0 (this device)K221383MedtFine Blood LancetShanghai Carelife International Trading Co., Ltd.2022—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199310
201210
FIG. 1 — Lineage of K221383, 1982–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QRK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QRK device

  1. #1 K221507 Disposable Blood Lancetscore 16.5 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K192666Promisemed Blood Lancet, VeriFine Safety Lancet, VeriFine Mini-Safety Lancet
Summary page 4
…ntegral Sharps Injury Prevention Feature Classification: Class II Product code: QRK 4. Predicate device Primary predicate device: Promisemed Blood Lancet - K192666 Reference device: Accu-Chek Softclix Blood Lancing System - K214022 5. Device description MedtFine Blood Lancet is a smal…
Promisemed Hangzhou Meditech Co., Ltd.2019—
†K214022Accu-Chek Softclix Blood Lancing SystemRoche Diabetes Care, Inc.2022—

Also cleared against K192666: 11 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 40 years and passes through 4 companies; a new generation was cleared every 9.1 years on median.
  • None of the 5 ancestors has a recall.
  • 11 other devices also cite its predicate K192666.

How does its category compare?

All QRK devices

QRK Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · QRK

2in 2025

2022: 32023: 72024: 32025: 22026 (partial year): 2
2007high 7 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QRK

55in 2024

2022: 100 days median2023: 89 days median2024: 55 days median
2007high 100 (2022) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QRK

No recall names QRK since 2007.

Adverse event reports per year · QRK

9in 2025

2022: 22023: 122024: 102025: 9
2007high 12 (2023) · low 0 (2007)2025

MAUDE reports naming product code QRK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
2022310002
2023789012
2024355010
20252—09
20262—0—

What is it indicated for?

MedtFine Blood Lancet is intended for use together with a lancing device for puncture of skin to obtain a drop of capillary blood from fingertip or from alternative sites.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K221383: MedtFine Blood Lancet.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K221383

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026